Area of research
Hepatology · Epidemiology
Research interest
Research interests include Medicine, Internal medicine, Hepatocellular carcinoma, Cohort, Cirrhosis, and Gastroenterology.
Evaluation of Sonographic Muscle Measurement Using Established Muscle Markers
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B
Treating hepatitis D with bulevirtide – Real-world experience from 114 patients
Metabolic dysfunction-associated fatty liver disease in people living with HIV
Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort
Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura
<i>Entamoeba histolytica</i>‐associated proctitis and ileitis mimicking Crohn's disease—A case report
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany
Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV
Bulevirtide treatment of hepatitis D in Germany: multicentre real-world experience
Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins
Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission
No Evidence for Classic Thrombotic Microangiopathy in COVID-19
Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study
Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C Patients
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis
Patterns of liver injury in COVID‐19 – a German case series
Clinical Frailty Scale for Risk Stratification in Patients with Sars-Cov-2 Infection
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study
Response: Frailty Assessment in the Covid-19 Pandemic
Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients
High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial
Sarcopenia as prognostic factor for survival after orthotopic liver transplantation
Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients
Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy